Abstract:Objective: To investigate the expression of glycoprotein non metastatic melanoma protein B (GPNMB) in renal eosinophilic tumors and to compare the value of GPNMB with CK20, CK7 and CD117 in the differential diagnosis of renal eosinophilic tumors. Methods: Traditional renal tumor eosinophil subtypes, including 22 cases of renal clear cell carcinoma eosinophil subtype (e-ccRCC), 19 cases of renal papillary cell carcinoma eosinophil subtype (e-papRCC), 17 cases of renal chromophobe cell carcinoma eosinophil subtype (e-chRCC), 12 cases of renal oncocytoma (RO) and emerging renal tumor types with eosinophil characteristics [3 cases of eosinophilic solid cystic renal cell carcinoma (ESC RCC), 3 cases of renal low-grade eosinophil tumor (LOT), 4 cases of fumarate hydratase-deficient renal cell carcinoma (FH-dRCC) and 5 cases of renal epithelioid angiomyolipoma (E-AML)], were collected at the Affiliated Drum Tower Hospital of Nanjing University Medical School from January 2017 to March 2022. The expression of GPNMB, CK20, CK7 and CD117 was detected by immunohistochemistry and statistically analyzed. Results: GPNMB was expressed in all emerging renal tumor types with eosinophil characteristics (ESC RCC, LOT, FH-dRCC) and E-AML, while the expression rates in traditional renal eosinophil subtypes e-papRCC, e-chRCC, e-ccRCC and RO were very low or zero (1/19, 1/17, 0/22 and 0/12, respectively); the expression rate of CK7 in LOT (3/3), e-chRCC (15/17), e-ccRCC (4/22), e-papRCC (2/19), ESC RCC (0/3), RO (4/12), E-AML(1/5), and FH-dRCC (2/4) variedly; the expression of CK20 was different in ESC RCC (3/3), LOT(3/3), e-chRCC(1/17), RO(9/12), e-papRCC(4/19), FH-dRCC(1/4), e-ccRCC(0/22) and E-AML(0/5), and so did that of CD117 in e-ccRCC(2/22), e-papRCC(1/19), e-chRCC(16/17), RO(10/12), ESC RCC(0/3), LOT(1/3), E-AML(2/5) and FH-dRCC(1/4). GPNMB had 100% sensitivity and 97.1% specificity in distinguishing E-AML and emerging renal tumor types (such as ESC RCC, LOT, FH-dRCC) from traditional renal tumor types (such as e-ccRCC, e-papRCC, e-chRCC, RO),respectively. Compared with CK7, CK20 and CD117 antibodies, GPNMB was more effective in the differential diagnosis (P<0.05). Conclusion: As a new renal tumor marker, GPNMB can effectively distinguish E-AML and emerging renal tumor types with eosinophil characteristics such as ESC RCC, LOT, FH-dRCC from traditional renal tumor eosinophil subtypes such as e-ccRCC, e-papRCC, e-chRCC and RO, which is helpful for the differential diagnosis of renal eosinophilic tumors.

GATA3 Expression in Solid Vimentin-Negative Eosinophilic Renal Epithelial Tumors—A Comprehensive Study of 48 Tumors

The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma

GATA3 expression in primary lung carcinomas: correlation with histopathologic features and TTF-1, napsin A, and p40 expression

GATA3 Aids in Distinguishing Fumarate Hydratase-Deficient Renal Cell Carcinoma from Papillary Renal Cell Carcinoma.

Characterisation of GATA3 Expression in Invasive Breast Cancer: Differences in Histological Subtypes and Immunohistochemically Defined Molecular Subtypes

GATA3 Expression in Prostatic Adenosquamous Carcinoma: A Potential Diagnostic Pitfall

Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort

[Renal eosinophilic vacuolated tumor: a clinicopathological analysis of seven cases]

Expression of GATA3 in breast tumor and its clinical significance

GATA 3 Gene Overexpression Is A Biomarker of Adverse Prognosis for Peripheral T-Cell Lymphoma, Not Otherwise Specified and for ALK-Negative Anaplastic Large Cell Lymphoma: An Exploratory Analysis of 80 Latin American Cases of nodal PTCLs

GATA3 expression in tumor‐infiltrating mononuclear inflammatory cells is associated with poor prognostic factors in tubo‐ovarian carcinomas

Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration

Gata3 is A Sensitive Marker for Primary Genital Extramammary Paget Disease: an Immunohistochemical Study of 72 Cases with Comparison to Gross Cystic Disease Fluid Protein 15

Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder

[Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis]

Expression Status of GATA3 and Mismatch Repair Proteins in Upper Tract Urothelial Carcinoma

[Expression of H3.3 G34W Mutant-Specific Antibody in Giant Cell Tumors of Bone and Its Diagnostic Value].

GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer

Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma

Clinicopathological Features and Prognosis of TFE3-positive Renal Cell Carcinoma

Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India